Europe Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • Europe
  • 350 Pages
  • No of Tables: 248
  • No of Figures: 56

Europe Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor [GIST], Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III and Stage IV), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe) Industry Trends and Forecast to 2028

Europe Gastric Cancer Diagnostics Market Market Analysis and Insights: Europe Gastric Cancer Diagnostics Market

 Europe gastric cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 371.76 million by 2028 from USD 228.01 million in 2020. The rising incidence of diabetes and growth of novel technological advancements for gastric cancer diagnostics assay are likely to be the major drivers which propel the demand of the market in the forecast period.

Stomach cancer is a type of cancer that starts in the stomach and spreads throughout the body. The stomach is a muscular pouch that lies immediately below your ribs in the upper part of your abdomen. Your stomach takes in and holds the food you eat before breaking it down and digesting it. Stomach cancer, commonly referred to as gastric cancer, can occur in any section of the stomach. Stomach cancers develop in the major section of the stomach in most parts of the world (stomach body). Various diagnostic tests used for diagnosis of cancer include prescreening tests, biopsy, biomarkers, imaging tests, PET/CT scan and ultrasound among others.

Increase in incidence of gastrointestinal tumors, lymphoma, and adenocarcinoma, Rise in alcohol consumptions and surge in smoking, increase in the geriatric population, strategic initiatives by key market players, recent advances in gastric cancer diagnostics is driving the market growth. However, high cost of testing and lack of sufficient financial support from health insurance policies is hampering the market growth. On the contrary, rising healthcare expenditure, adoption of automated systems, increased research and development on cancer diagnostics. Furthermore, stringent regulations and policies for approving the complicated nature of radiation devices and limitations of radiation tests.

The gastric cancer diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the gastric cancer diagnostics market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Gastric Cancer Diagnostics Market Gastric Cancer Diagnostics Market Scope and Market Size

The gastric cancer diagnostics market is segmented on the basis of the product type, diagnostics type, age group, stage, gender, sample type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the gastric cancer diagnostics market is segmented into instruments, reagents & consumables, and services. In 2021, the reagents & consumables segment is expected to dominate the gastric cancer diagnostics market because number of top players developing kits for gastric cancer diagnostics, and wider range of kits products available in the market. Moreover, IVD players are also focusing on the development of more advanced kits.
  • On the basis of diagnostics type, the gastric cancer diagnostics market is segmented into gastric (pre) cancer screening tests/physical exam and confirmatory tests. In 2021, the confirmatory tests segment is expected to dominate the gastric cancer diagnostics market because most of the diagnostics have been done with imaging techniques such as endoscopic Ultrasonography, PET-CT scan and CT scan.
  • On the basis of age group, the gastric cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, the geriatric segment is expected to dominate the gastric cancer diagnostics market because geriatric population is more vulnerable to stomach cancer and prevalence of stomach cancer above 45 age is also high.
  • On the basis of type, the gastric cancer diagnostics market is segmented into intestinal or diffuse adenocarcinoma, carcinoid tumor, gastrointestinal stromal tumor [GIST], gastric lymphoma and others. In 2021, the intestinal or diffuse adenocarcinoma segment is expected to dominate the gastric cancer diagnostics market because of increase in prevalence of intestinal or diffuse adenocarcinoma type of stomach cancer.
  • On the basis of stage, the gastric cancer diagnostics market is segmented into Stage 0, Stage I, Stage II, Stage III and Stage IV. In 2021, the stage I segment is expected to dominate the gastric cancer diagnostics market because maximum number of confirmatory tests performed for stage I to diagnose stomach cancer at early stage.
  • On the basis of gender, the gastric cancer diagnostics market is segmented into male and female. In 2021, the male segment is expected to dominate the gastric cancer diagnostics market because men are more often to develop stomach cancer than female.
  • On the basis of sample type, the gastric cancer diagnostics market is segmented into blood, tissue, urine, and stool. In 2021, the stool segment is expected to dominate the gastric cancer diagnostics market because most of the diagnostics tests performed of stool sample as well as availability of stool diagnostic products provided with the companies.
  • On the basis of end users, the gastric cancer diagnostics market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics and others. In 2021, the hospitals segment is expected to dominate the gastric cancer diagnostics market due to large number of diagnostics tests for stomach cancer have been performed in the hospitals ly.
  • On the basis of distribution channel, the gastric cancer diagnostics market is segmented into direct tender and retail sales. In 2021, the direct tenders segment is expected to dominate the gastric cancer diagnostics market due to high cost of instruments hospitals prefer purchasing products in bulk quantity to reduce procurement cost.

Gastric Cancer Diagnostics Market Country Level Analysis

The gastric cancer diagnostics market is analysed and market size information is provided by the country, product type, diagnostics type, age group, stage, gender, sample type, end user and distribution channel as referenced above.

The countries covered in the gastric cancer diagnostics Market report are the Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, and Rest of Europe.

Europe is expected to grow with the highest CAGR in the forecasted periods as in the Europe’s Countries demand for gastric cancer diagnostics product is increasing very rapidly with the urbanization due to increase in prevalence across the globe. Germany is expected to dominate and fastest in the market in the Europe market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing strategic activities by major market players to enhance the awareness for gastric cancer diagnostics is boosting the market growth of gastric cancer diagnostics market

The gastric cancer diagnostics market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Europe Gastric Cancer Diagnostics Market Share Analysis

Gastric cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to gastric cancer diagnostics market.

The major companies which are dealing in the gastric cancer diagnostics are bioMérieux SA , Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Agilent Technologies, Inc., Endofotonics Pte Ltd, Biohit Oyj, BIOCEPT, INC., FOUNDATION MEDICINE, INC., DiaSorin S.p.A, Paragon Genomics, Inc. and QIAGEN, ACON Laboratories, Inc., Teco Diagnostics., Vela Diagnostics , Abbott, AdvaCare Pharma, MiRXES, Fujirebio ( An H.U. Group company), Thermo Fisher Scientific Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the gastric cancer diagnostics market.

For instance,

  • In March 2020, Thermo Fisher Scientific announced that it will be acquiring QIAGEN, a Netherland based molecular diagnostics and healthcare company. This acquisition by the company will increase its product portfolio in the market, leading to increased revenue in future

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the gastric cancer diagnostics market which also provides the benefit for organization’s profit growth.

Customization Available: Europe Gastric Cancer Diagnostics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 EUROPE REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 EUROPE REAGENT AND CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 EUROPE KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 5 EUROPE REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 EUROPE INSTRUMENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE SERVICES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 9 EUROPE CONFIRMATORY TEST IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE CONFIRMATORY TEST IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 11 EUROPE IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 12 EUROPE BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 13 EUROPE GASTRIC CANCER SCREENING TESTS/PHYSICAL EXAM IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 15 EUROPE GERIATRICS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE ADULT IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE PEDIATRIC IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 19 EUROPE INTESTINAL OR DIFFUSE ADENOCARCINOMA IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE CARCINOID TUMOR IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE GASTROINTESTINAL STROMAL TUMOR IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE GASTRIC LYMPHOMA IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE OTHERS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 25 EUROPE STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 27 EUROPE STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 29 EUROPE STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 31 EUROPE STAGE 0 IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 33 EUROPE MALE IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE FEMALE IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 36 EUROPE STOOL IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE TISSUE IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 EUROPE BLOOD IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE URINE IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 41 EUROPE HOSPITALS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 EUROPE DIAGNOSTIC LABORATORIES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE CANCER RESEARCH INSTITUTES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE ONCOLOGY SPECIALTY CLINICS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 EUROPE OTHERS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 47 EUROPE DIRECT TENDERS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 EUROPE RETAIL SALES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 50 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 51 EUROPE REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 52 EUROPE KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 53 EUROPE REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 54 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 55 EUROPE CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 56 EUROPE IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 57 EUROPE BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 58 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 59 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 60 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 61 EUROPE STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 62 EUROPE STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 63 EUROPE STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 64 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 65 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 66 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 67 EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 68 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 69 GERMANY REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 70 GERMANY KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 71 GERMANY REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 73 GERMANY CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 74 GERMANY IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 75 GERMANY BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 76 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 77 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 78 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 79 GERMANY STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 80 GERMANY STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 81 GERMANY STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 82 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 83 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 84 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 85 GERMANY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 87 FRANCE REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 88 FRANCE KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 89 FRANCE REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 90 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 91 FRANCE CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 92 FRANCE IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 93 FRANCE BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 94 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 95 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 96 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 97 FRANCE STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 98 FRANCE STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 99 FRANCE STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 100 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 101 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 102 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 103 FRANCE GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 104 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 105 U.K. REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 106 U.K. KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 107 U.K. REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 108 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 109 U.K. CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 110 U.K. IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 111 U.K. BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 112 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 113 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 114 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 115 U.K. STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 116 U.K. STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 117 U.K. STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 118 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 119 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 120 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 121 U.K. GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 122 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 123 RUSSIA REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 124 RUSSIA KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 125 RUSSIA REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 126 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 127 RUSSIA CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 128 RUSSIA IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 129 RUSSIA BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 130 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 131 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 132 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 133 RUSSIA STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 134 RUSSIA STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 135 RUSSIA STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 136 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 137 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 138 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 139 RUSSIA GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 140 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 141 ITALY REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 142 ITALY KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 143 ITALY REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 144 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 145 ITALY CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 146 ITALY IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 147 ITALY BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 148 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 149 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 150 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 151 ITALY STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 152 ITALY STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 153 ITALY STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 154 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 155 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 156 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 157 ITALY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 158 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 159 SPAIN REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 160 SPAIN KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 161 SPAIN REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 162 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 163 SPAIN CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 164 SPAIN IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 165 SPAIN BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 166 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 167 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 168 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 169 SPAIN STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 170 SPAIN STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 171 SPAIN STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 172 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 173 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 174 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 175 SPAIN GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 176 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 177 BELGIUM REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 178 BELGIUM KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 179 BELGIUM REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 180 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 181 BELGIUM CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 182 BELGIUM IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 183 BELGIUM BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 184 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 185 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 186 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 187 BELGIUM STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 188 BELGIUM STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 189 BELGIUM STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 190 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 191 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 192 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 193 BELGIUM GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 194 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 195 NETHERLANDS REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 196 NETHERLANDS KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 197 NETHERLANDS REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 198 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 199 NETHERLANDS CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 200 NETHERLANDS IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 201 NETHERLANDS BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 202 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 203 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 204 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 205 NETHERLANDS STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 206 NETHERLANDS STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 207 NETHERLANDS STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 208 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 209 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 210 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 211 NETHERLANDS GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 212 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 213 TURKEY REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 214 TURKEY KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 215 TURKEY REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 216 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 217 TURKEY CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 218 TURKEY IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 219 TURKEY BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 220 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 221 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 222 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 223 TURKEY STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 224 TURKEY STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 225 TURKEY STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 226 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 227 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 228 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 229 TURKEY GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 230 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 231 SWITZERLAND REAGENTS & CONSUMABLES IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 232 SWITZERLAND KITS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 233 SWITZERLAND REAGENTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 234 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 235 SWITZERLAND CONFIRMATORY TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 236 SWITZERLAND IMAGING TESTS IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 237 SWITZERLAND BIOMARKER IN GASTRIC CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE, 2019-2028 (USD MILLION)

TABLE 238 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 239 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 240 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 241 SWITZERLAND STAGE I IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 242 SWITZERLAND STAGE II IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 243 SWITZERLAND STAGE III IN GASTRIC CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 244 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 245 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 246 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 247 SWITZERLAND GASTRIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 248 REST OF EUROPE GASTRIC CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions